DaVita Inc. Shares - Insider sale and technical picture on Thursday
Published on 06/18/2026 at 17:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 17:42 CET. Details in the imprint.
DaVita Inc. (US23918K1088) is drawing attention on Thursday after a reported insider sale and a still robust technical setup. According to a Moomoo News item dated 06/17/2026, officer Javier Rodriguez sold roughly $14.53 million worth of common stock earlier this week.
All news and analysis on DaVita Inc. stock
Follow DaVita Inc. stock for updates on insider transactions, chart signals and upcoming corporate events.
Details of the insider sale
The Moomoo report states that DaVita officer Javier Rodriguez sold 69,407 shares of common stock on 06/15 and 06/16/2026 at an average price of $209.38, corresponding to proceeds of about $14.53 million.
Such insider sales are typically disclosed in Form 4 filings with the US Securities and Exchange Commission, although the latest filing data were not immediately visible in public SEC summaries at the time of writing.
Chart levels and Thursday focus
On the technical side, DaVita shares recently traded around $208, with intraday levels between roughly $207.10 and $213.07 according to real-time data from Investing.com’s DaVita chart page. Investing.com data for DVA
TradingKey’s technical overview puts the stock between a support level near $193.65 and resistance around $220.48, with several moving averages still pointing to a buy signal for the current trend. TradingKey technical view on DaVita
How DaVita makes its money
DaVita’s core business is providing kidney care services, with a focus on chronic kidney disease and end-stage renal disease patients treated through in-center and home hemodialysis as well as peritoneal dialysis programs across its clinic network.
Where the stock trades today
DaVita Inc. shares (US23918K1088) trade on the New York Stock Exchange at about $208.28 as of 06/18/2026, 17:30 CET, based on recent consolidated price data in US dollars.
Key facts on DaVita Inc. stock
- Company: DaVita Inc.
- ISIN: US23918K1088
- WKN: 897914
- Ticker: DVA
- Venue: NYSE
- Price (as of 06/18/2026, 17:30 CET): 208.28 USD
- Market cap: 13.78 billion USD (as of 06/18/2026)
- Sector / Industry: Health Care - Health Care Providers & Services
- Index membership: Standard & Poor's 500 index
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
